Rankings
▼
Calendar
PMVP Q4 2024 Earnings — PMV Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
PMVP
PMV Pharmaceuticals, Inc.
$88M
Q4 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$25M
Net Income
-$23M
EPS (Diluted)
$0.37
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$17M
Free Cash Flow
-$17M
Stock-Based Comp.
$1M
Balance Sheet
Total Assets
$191M
Total Liabilities
$15M
Stockholders' Equity
$176M
Cash & Equivalents
$41M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
-$359,000
+100.0%
Operating Income
-$25M
-$19M
-33.1%
Net Income
-$23M
-$16M
-46.0%
← FY 2024
All Quarters
Q1 2025 →